If you have spent any time in an Ayurvedic pharmacy or spoken to a vaidya about perimenopausal symptoms, you may have come across vidarikand, a starchy tuberous root sold as powder, as a component of classical formulations, or as a standalone “women’s rasayana” capsule. It is less well known outside Ayurvedic circles than shatavari or ashwagandha, but it occupies a similar traditional category: a rejuvenative tonic specifically associated with women’s reproductive health. Given how many named herbs this series has already covered, it is worth looking at vidarikand on its own terms: what it traditionally claims to do, and what current research can and cannot confirm.

Quick Answer

Vidarikand, the tuber of Pueraria tuberosa, is traditionally classified in Ayurveda as a rasayana (rejuvenative) herb used for general vitality, lactation support, and women's reproductive health, often within compound formulations rather than alone. It is related to other Pueraria species studied for isoflavone content, but dedicated clinical research on vidarikand specifically in perimenopausal women is sparse, mostly limited to animal and laboratory studies. It should never be treated as a substitute for medical evaluation of hormonal symptoms, and anyone with a history of hormone-sensitive cancer should be especially cautious and discuss it with their doctor first.

  • Traditionally classified as a rasayana, a general rejuvenative tonic, not a targeted treatment for hot flashes or mood
  • Historically used to support lactation and general reproductive vitality, usually within compound formulations
  • Contains plant compounds similar in class to isoflavones studied in related Pueraria species, but human trial evidence specific to vidarikand is limited
  • Not studied in dedicated, well-designed trials on perimenopausal hot flashes, sleep, or mood
  • Always disclose use to your doctor, particularly if you have a personal or family history of hormone-sensitive cancer
Vidarikand: Tradition vs Evidence

Traditional Ayurvedic use

General rasayana (rejuvenative) tonic, support for lactation, reproductive vitality, and recovery after illness, usually combined with other herbs in classical formulations rather than taken alone.

What current research shows

Mostly animal and laboratory studies on plant compounds and general tonic effects; isoflavone-type compounds are present, but dedicated human trials in perimenopausal women specifically are essentially absent.

What Is Vidarikand, and Why Is It Grouped with Women’s Health Herbs?

Vidarikand is the Sanskrit and Ayurvedic name for the tuberous root of Pueraria tuberosa, a climbing vine found across parts of India, sometimes called Indian Kudzu because it belongs to the same broader plant genus as the Pueraria species studied in East Asia for their phytoestrogen content. In classical Ayurvedic texts, vidarikand is classified as a rasayana, a broad category of herbs believed to support general rejuvenation, strength, and resilience, rather than a herb aimed at one specific symptom or organ system.

Its traditional reputation for women’s health comes mainly from its historical use to support lactation in nursing mothers and as a general reproductive tonic believed to nourish tissue and support strength during recovery from illness or childbirth. This is a somewhat different traditional role from, say, shatavari, which is more specifically tied to menstrual and reproductive health across the lifespan, including perimenopause. Vidarikand’s traditional use case is broader and less specifically targeted at the hormonal transition itself.

Does Vidarikand Have Any Hormone-Like Effect?

Because vidarikand belongs to the same genus as Pueraria species studied for isoflavone content, there is a reasonable biological basis to ask whether it behaves similarly, but the honest answer is that this has not been well established in humans. Laboratory and animal studies on Pueraria tuberosa extract have identified some plant compounds structurally similar to isoflavones, the class of phytoestrogens also found in soy, and some preliminary research has looked at its effects on bone density and lipid markers in animal models.

What is missing is the kind of well-designed human clinical trial that would tell us whether vidarikand meaningfully reduces hot flashes, improves sleep, or affects mood in perimenopausal women specifically. Unlike black cohosh, red clover, or soy isoflavones, which have at least some dedicated human trials in menopausal populations even if the results are mixed, vidarikand simply has not been studied this way in any robust form that this series could identify. Any claim that it “balances hormones” during perimenopause is, at present, an extrapolation from related plant chemistry rather than a demonstrated clinical effect.

How Is Vidarikand Typically Used, and What Should You Know Before Trying It?

Vidarikand is most commonly available in India as a powder (churna), often mixed into milk, or as an ingredient within compound Ayurvedic formulations aimed at general strength, lactation support, or reproductive health, rather than sold as a standalone capsule with a standardised extract the way some newer supplements are marketed. This matters practically: when it is one ingredient among several in a classical formulation, it is difficult to know how much vidarikand you are actually consuming, or whether any effect you notice comes from this herb specifically or from the formulation as a whole.

A qualified Ayurvedic practitioner should be consulted for personalised guidance on whether vidarikand fits your constitution and symptom picture, rather than self-selecting it based on online claims. This is especially true because rasayana herbs in classical Ayurveda are traditionally prescribed as part of a broader individualised plan involving diet and daily routine, not as an isolated supplement taken in the way a modern vitamin capsule is used.

HerbPrimary traditional useHuman clinical evidence for perimenopause
ShatavariWomen’s reproductive health across the lifespanSome small trials, mixed results
AshwagandhaStress, vitality, adaptogenic supportReasonable evidence for stress and sleep
VidarikandGeneral rasayana, lactation support, vitalityMinimal, mostly non-human studies

In the Indian Context

Vidarikand is widely available in Indian Ayurvedic pharmacies, usually at a modest price compared to some of the more heavily marketed herbal supplements, often sold as a plain powder rather than a branded capsule. This can be an advantage in terms of cost, but it also means quality and actual tuber content can vary considerably between suppliers, since India’s herbal and supplement market remains loosely regulated for standardisation and purity testing.

If a family member or an Ayurvedic practitioner has suggested vidarikand as part of a broader plan for perimenopausal symptoms, it is reasonable to try it as a complementary measure while continuing to track your symptoms and keep your gynaecologist informed, particularly if you are also considering or already using hormone therapy. Never let a herbal tonic, however traditional and well-regarded, delay a proper medical evaluation of symptoms like irregular bleeding, significant mood changes, or hot flashes that are substantially affecting your quality of life. If you are unsure where to start that conversation, our free symptom check can help you organise what to raise with your doctor.

Frequently Asked Questions

Is vidarikand the same as shatavari? No. Both are classified as rasayanas associated with women’s health in Ayurveda, but shatavari has a more specific traditional and research focus on reproductive and menstrual health, while vidarikand’s traditional use centres more on general vitality and lactation support.

Can vidarikand help with hot flashes specifically? There is no good direct evidence for this. Its traditional use is broader than targeted hot flash relief, and dedicated human research on this specific symptom in perimenopausal women does not currently exist.

Is vidarikand safe to take alongside hormone therapy? Possibly, but always tell your doctor you are using it, since interaction data with hormone therapy has not been specifically studied and your doctor needs the full picture of everything you are taking.

Who should be especially cautious with vidarikand? Anyone with a personal or family history of hormone-sensitive cancer, since its isoflavone-type compounds have a theoretical oestrogen-like action, and anyone who is pregnant or breastfeeding without medical supervision, given the limited safety data available.

The Second Spring is an information resource, not a medical provider. For personal advice, speak with your doctor or gynaecologist. Write to us at thesecondspringofficial@gmail.com